Vanda Pharmaceuticals Inc.

General ticker "VNDA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $281.1M

Vanda Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 29.5%.

Estimated limits based on current volatility of 2.2%: low 4.64$, high 4.85$

Factors to consider:

  • US accounted for 100.0% of revenue in the fiscal year ended 2022-12-31
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.40$, 4.90$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.98$, 5.60$]

Financial Metrics affecting the VNDA estimates:

  • Negative: Non-GAAP EPS, $ of 0.05 <= 0.10
  • Negative: Operating profit margin, % of -6.75 <= 1.03
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Inventory ratio change, % of 0.23 <= 1.08
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
  • Positive: -0.96 < Investing cash flow per share, $ of -0.21
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term VNDA quotes

Long-term VNDA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $268.68MM $254.38MM $192.64MM
Operating Expenses $226.52MM $248.05MM $206.59MM
Operating Income $42.16MM $6.33MM $-13.95MM
Non-Operating Income $0.20MM $4.97MM $20.29MM
R&D Expense $75.36MM $85.77MM $76.82MM
Income(Loss) $42.36MM $11.30MM $6.34MM
Taxes $9.21MM $5.03MM $3.83MM
Profit(Loss) $33.15MM $6.28MM $2.51MM
Stockholders Equity $504.93MM $527.20MM $544.91MM
Inventory $1.02MM $1.19MM $1.36MM
Assets $593.79MM $634.25MM $648.44MM
Operating Cash Flow $64.21MM $31.98MM $12.80MM
Capital expenditure $0.55MM $0.68MM $0.38MM
Investing Cash Flow $-76.70MM $49.92MM $-12.06MM
Financing Cash Flow $3.55MM $0.73MM $0.00MM
Earnings Per Share* $0.60 $0.11 $0.04

* EPS are Split Adjusted, recent splits may be reflected with a delay.